ESSKA/ESMA ACL Injury Prevention Program in Czech Sport
Launched by MASARYK UNIVERSITY · Jun 5, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on preventing ACL (anterior cruciate ligament) injuries in young athletes, especially those aged 17 to 20 who are involved in sports that put them at a higher risk for these kinds of injuries. The program will use a combination of exercises aimed at strengthening muscles, improving flexibility, and teaching safe movement techniques. Coaches, physiotherapists, and doctors will work together to create a personalized training plan for each participant, helping them avoid injuries while playing sports.
To be eligible for this study, participants should be between 17 and 20 years old, actively participating in sports, and have no significant previous knee injuries. They must also be willing to regularly attend training sessions and assessments. Those with current knee injuries or chronic health conditions that could affect their safety or participation will not be included. Throughout the program, participants can expect to engage in targeted exercises and receive education on how to move safely, which can help them stay injury-free and improve their athletic performance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age group: Participants aged 17-20 years
- • Sports activity: Individuals actively engaged in sports with a high risk of ACL injury
- • Health status: Participants with no or minimal previous knee joint injuries that do not limit their current physical activity
- • Willingness to participate: Agreement to take part in the prevention program, including regular training and assessments
- • Informed consent: Signed informed consent for participation in the program and testing procedures; for minors, consent must be signed by legal guardians
- Exclusion Criteria:
- • Current injury: Individuals with a current knee joint injury requiring treatment or surgery
- • Chronic conditions: Participants with chronic diseases or conditions that may affect the outcome of injury prevention (e.g., congenital abnormalities, neuromuscular disorders, or cardiovascular diseases)
- • Insufficient consent: Individuals who are unable or unwilling to provide written informed consent
- • Irregular participation: Individuals who do not comply with regular participation in the training program or assessments
About Masaryk University
Masaryk University, located in Brno, Czech Republic, is a leading academic institution renowned for its commitment to advancing research and education in the life sciences and clinical fields. As a sponsor of clinical trials, the university leverages its extensive resources, including state-of-the-art laboratories and a multidisciplinary team of experts, to conduct innovative research that addresses critical health challenges. With a focus on ethical standards and regulatory compliance, Masaryk University aims to contribute to the development of new therapeutic approaches and improve patient outcomes through rigorous scientific inquiry and collaboration with healthcare partners.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brno, , Czechia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported